Cancer Investigation This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

THE NATURE, ORIGIN AND EVOLUTION OF LIFE: Part I The Fundamental Logic and Organization of Life
Cancer Invest. 2023 Sep 21:1-4. doi: 10.1080/07357907.2023.2262122. Online ahead of print.NO ABSTRACTPMID:37732739 | DOI:10.1080/07357907.2023.2262122 (Source: Cancer Investigation)
Source: Cancer Investigation - September 21, 2023 Category: Cancer & Oncology Authors: Gary H Lyman Christopher H Lyman Nicole M Kuderer Source Type: research

Correction
Cancer Invest. 2023 Sep 21:1. doi: 10.1080/07357907.2023.2259655. Online ahead of print.NO ABSTRACTPMID:37733418 | DOI:10.1080/07357907.2023.2259655 (Source: Cancer Investigation)
Source: Cancer Investigation - September 21, 2023 Category: Cancer & Oncology Source Type: research

Drug Repurposing Analysis for Colorectal Cancer through Network Medicine Framework: Novel Candidate Drugs and Small Molecules
This study aimed to reveal the drug-repurposing candidates for colorectal cancer (CRC) via drug-repurposing methods and network biology approaches. A novel, differentially co-expressed, highly interconnected, and co-regulated prognostic gene module was identified for CRC. Based on the gene module, polyethylene glycol (PEG), gallic acid, pyrazole, cordycepin, phenothiazine, pantoprazole, cysteamine, indisulam, valinomycin, trametinib, BRD-K81473043, AZD8055, dovitinib, BRD-A17065207, and tyrphostin AG1478 presented as drugs and small molecule candidates previously studied in the CRC. Lornoxicam, suxamethonium, oprelvekin, s...
Source: Cancer Investigation - September 8, 2023 Category: Cancer & Oncology Authors: Ulku Unal Esra Gov Source Type: research

Drug repurposing analysis for colorectal cancer through network medicine framework: Novel candidate drugs and small molecules
This study aimed to reveal the drug repurposing candidates for colorectal cancer (CRC) via drug repurposing methods and network biology approaches. A novel, differentially co-expressed, highly interconnected, and co-regulated prognostic gene module was identified for CRC. Based on the gene module, polyethylene glycol, gallic acid, pyrazole, cordycepin, phenothiazine, pantoprazole, cysteamine, indisulam, valinomycin, trametinib, BRD-K81473043, AZD8055, dovitinib, BRD-A17065207, and tyrphostin AG1478 presented as drugs and small molecule candidates previously studied in the CRC. Lornoxicam, suxamethonium, oprelvekin, sirukum...
Source: Cancer Investigation - September 8, 2023 Category: Cancer & Oncology Authors: Ulku Unal Esra Gov Source Type: research